Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
Identifieur interne : 001008 ( PubMed/Corpus ); précédent : 001007; suivant : 001009Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
Auteurs : Delphine Gabillard ; Charlotte Lewden ; Ibra Ndoye ; Raoul Moh ; Olivier Segeral ; Besigin Tonwe-Gold ; Jean-François Etard ; Men Pagnaroat ; Isabelle Fournier-Nicolle ; Serge Eholié ; Issouf Konate ; Albert Minga ; Eitel Mpoudi-Ngole ; Sinata Koulla-Shiro ; Djimon Marcel Zannou ; Xavier Anglaret ; Christian LaurentSource :
- Journal of acquired immune deficiency syndromes (1999) [ 1944-7884 ] ; 2013.
English descriptors
- KwdEn :
- Acquired Immunodeficiency Syndrome (drug therapy), Acquired Immunodeficiency Syndrome (mortality), Acquired Immunodeficiency Syndrome (virology), Adolescent, Adult, Africa South of the Sahara (epidemiology), Anti-HIV Agents (therapeutic use), Asia (epidemiology), CD4 Lymphocyte Count, Cohort Studies, Female, HIV Infections (drug therapy), HIV Infections (mortality), HIV Infections (virology), HIV-1 (isolation & purification), Humans, Incidence, Linear Models, Male, Young Adult.
- MESH :
- chemical , therapeutic use : Anti-HIV Agents.
- geographic , epidemiology : Africa South of the Sahara, Asia.
- drug therapy : Acquired Immunodeficiency Syndrome, HIV Infections.
- isolation & purification : HIV-1.
- mortality : Acquired Immunodeficiency Syndrome, HIV Infections.
- virology : Acquired Immunodeficiency Syndrome, HIV Infections.
- Adolescent, Adult, CD4 Lymphocyte Count, Cohort Studies, Female, Humans, Incidence, Linear Models, Male, Young Adult.
Abstract
In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions.
DOI: 10.1097/QAI.0b013e3182821821
PubMed: 23274931
Links to Exploration step
pubmed:23274931Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.</title><author><name sortKey="Gabillard, Delphine" sort="Gabillard, Delphine" uniqKey="Gabillard D" first="Delphine" last="Gabillard">Delphine Gabillard</name><affiliation><nlm:affiliation>INSERM, U897, Université Bordeaux Segalen, Bordeaux, France. delphine.gabillard@isped.u-bordeaux2.fr</nlm:affiliation></affiliation></author><author><name sortKey="Lewden, Charlotte" sort="Lewden, Charlotte" uniqKey="Lewden C" first="Charlotte" last="Lewden">Charlotte Lewden</name></author><author><name sortKey="Ndoye, Ibra" sort="Ndoye, Ibra" uniqKey="Ndoye I" first="Ibra" last="Ndoye">Ibra Ndoye</name></author><author><name sortKey="Moh, Raoul" sort="Moh, Raoul" uniqKey="Moh R" first="Raoul" last="Moh">Raoul Moh</name></author><author><name sortKey="Segeral, Olivier" sort="Segeral, Olivier" uniqKey="Segeral O" first="Olivier" last="Segeral">Olivier Segeral</name></author><author><name sortKey="Tonwe Gold, Besigin" sort="Tonwe Gold, Besigin" uniqKey="Tonwe Gold B" first="Besigin" last="Tonwe-Gold">Besigin Tonwe-Gold</name></author><author><name sortKey="Etard, Jean Francois" sort="Etard, Jean Francois" uniqKey="Etard J" first="Jean-François" last="Etard">Jean-François Etard</name></author><author><name sortKey="Pagnaroat, Men" sort="Pagnaroat, Men" uniqKey="Pagnaroat M" first="Men" last="Pagnaroat">Men Pagnaroat</name></author><author><name sortKey="Fournier Nicolle, Isabelle" sort="Fournier Nicolle, Isabelle" uniqKey="Fournier Nicolle I" first="Isabelle" last="Fournier-Nicolle">Isabelle Fournier-Nicolle</name></author><author><name sortKey="Eholie, Serge" sort="Eholie, Serge" uniqKey="Eholie S" first="Serge" last="Eholié">Serge Eholié</name></author><author><name sortKey="Konate, Issouf" sort="Konate, Issouf" uniqKey="Konate I" first="Issouf" last="Konate">Issouf Konate</name></author><author><name sortKey="Minga, Albert" sort="Minga, Albert" uniqKey="Minga A" first="Albert" last="Minga">Albert Minga</name></author><author><name sortKey="Mpoudi Ngole, Eitel" sort="Mpoudi Ngole, Eitel" uniqKey="Mpoudi Ngole E" first="Eitel" last="Mpoudi-Ngole">Eitel Mpoudi-Ngole</name></author><author><name sortKey="Koulla Shiro, Sinata" sort="Koulla Shiro, Sinata" uniqKey="Koulla Shiro S" first="Sinata" last="Koulla-Shiro">Sinata Koulla-Shiro</name></author><author><name sortKey="Zannou, Djimon Marcel" sort="Zannou, Djimon Marcel" uniqKey="Zannou D" first="Djimon Marcel" last="Zannou">Djimon Marcel Zannou</name></author><author><name sortKey="Anglaret, Xavier" sort="Anglaret, Xavier" uniqKey="Anglaret X" first="Xavier" last="Anglaret">Xavier Anglaret</name></author><author><name sortKey="Laurent, Christian" sort="Laurent, Christian" uniqKey="Laurent C" first="Christian" last="Laurent">Christian Laurent</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23274931</idno><idno type="pmid">23274931</idno><idno type="doi">10.1097/QAI.0b013e3182821821</idno><idno type="wicri:Area/PubMed/Corpus">001008</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001008</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.</title><author><name sortKey="Gabillard, Delphine" sort="Gabillard, Delphine" uniqKey="Gabillard D" first="Delphine" last="Gabillard">Delphine Gabillard</name><affiliation><nlm:affiliation>INSERM, U897, Université Bordeaux Segalen, Bordeaux, France. delphine.gabillard@isped.u-bordeaux2.fr</nlm:affiliation></affiliation></author><author><name sortKey="Lewden, Charlotte" sort="Lewden, Charlotte" uniqKey="Lewden C" first="Charlotte" last="Lewden">Charlotte Lewden</name></author><author><name sortKey="Ndoye, Ibra" sort="Ndoye, Ibra" uniqKey="Ndoye I" first="Ibra" last="Ndoye">Ibra Ndoye</name></author><author><name sortKey="Moh, Raoul" sort="Moh, Raoul" uniqKey="Moh R" first="Raoul" last="Moh">Raoul Moh</name></author><author><name sortKey="Segeral, Olivier" sort="Segeral, Olivier" uniqKey="Segeral O" first="Olivier" last="Segeral">Olivier Segeral</name></author><author><name sortKey="Tonwe Gold, Besigin" sort="Tonwe Gold, Besigin" uniqKey="Tonwe Gold B" first="Besigin" last="Tonwe-Gold">Besigin Tonwe-Gold</name></author><author><name sortKey="Etard, Jean Francois" sort="Etard, Jean Francois" uniqKey="Etard J" first="Jean-François" last="Etard">Jean-François Etard</name></author><author><name sortKey="Pagnaroat, Men" sort="Pagnaroat, Men" uniqKey="Pagnaroat M" first="Men" last="Pagnaroat">Men Pagnaroat</name></author><author><name sortKey="Fournier Nicolle, Isabelle" sort="Fournier Nicolle, Isabelle" uniqKey="Fournier Nicolle I" first="Isabelle" last="Fournier-Nicolle">Isabelle Fournier-Nicolle</name></author><author><name sortKey="Eholie, Serge" sort="Eholie, Serge" uniqKey="Eholie S" first="Serge" last="Eholié">Serge Eholié</name></author><author><name sortKey="Konate, Issouf" sort="Konate, Issouf" uniqKey="Konate I" first="Issouf" last="Konate">Issouf Konate</name></author><author><name sortKey="Minga, Albert" sort="Minga, Albert" uniqKey="Minga A" first="Albert" last="Minga">Albert Minga</name></author><author><name sortKey="Mpoudi Ngole, Eitel" sort="Mpoudi Ngole, Eitel" uniqKey="Mpoudi Ngole E" first="Eitel" last="Mpoudi-Ngole">Eitel Mpoudi-Ngole</name></author><author><name sortKey="Koulla Shiro, Sinata" sort="Koulla Shiro, Sinata" uniqKey="Koulla Shiro S" first="Sinata" last="Koulla-Shiro">Sinata Koulla-Shiro</name></author><author><name sortKey="Zannou, Djimon Marcel" sort="Zannou, Djimon Marcel" uniqKey="Zannou D" first="Djimon Marcel" last="Zannou">Djimon Marcel Zannou</name></author><author><name sortKey="Anglaret, Xavier" sort="Anglaret, Xavier" uniqKey="Anglaret X" first="Xavier" last="Anglaret">Xavier Anglaret</name></author><author><name sortKey="Laurent, Christian" sort="Laurent, Christian" uniqKey="Laurent C" first="Christian" last="Laurent">Christian Laurent</name></author></analytic><series><title level="j">Journal of acquired immune deficiency syndromes (1999)</title><idno type="eISSN">1944-7884</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acquired Immunodeficiency Syndrome (drug therapy)</term><term>Acquired Immunodeficiency Syndrome (mortality)</term><term>Acquired Immunodeficiency Syndrome (virology)</term><term>Adolescent</term><term>Adult</term><term>Africa South of the Sahara (epidemiology)</term><term>Anti-HIV Agents (therapeutic use)</term><term>Asia (epidemiology)</term><term>CD4 Lymphocyte Count</term><term>Cohort Studies</term><term>Female</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (mortality)</term><term>HIV Infections (virology)</term><term>HIV-1 (isolation & purification)</term><term>Humans</term><term>Incidence</term><term>Linear Models</term><term>Male</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Africa South of the Sahara</term><term>Asia</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>HIV-1</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term><term>HIV Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>CD4 Lymphocyte Count</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Linear Models</term><term>Male</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23274931</PMID><DateCreated><Year>2013</Year><Month>06</Month><Day>13</Day></DateCreated><DateCompleted><Year>2013</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1944-7884</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of acquired immune deficiency syndromes (1999)</Title><ISOAbbreviation>J. Acquir. Immune Defic. Syndr.</ISOAbbreviation></Journal><ArticleTitle>Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.</ArticleTitle><Pagination><MedlinePgn>555-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/QAI.0b013e3182821821</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We pooled data from 13 research cohorts in 5 sub-Saharan African (Benin, Burkina Faso, Cameroon, Cote d'Ivoire, and Senegal) and 2 Asian (Cambodia and Laos) countries. HIV-infected adults (18 years and older) who received ART in 1998-2008 and had at least one CD4 count available were eligible. Changes in CD4 counts over time were estimated by a linear mixed regression. CD4-specific incidence rates were estimated as the number of first events occurring in a given CD4 stratum divided by the time spent within the stratum.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall 3917 adults (62% women) on ART were followed up during 10,154 person-years. In the ≤ 50, 51-100, 101-200, 201-350, 351-500, 501-650, and >650 cells/mm CD4 cells strata, death rates were 20.6, 11.8, 6.7, 3.3, 1.8, 0.9, and 0.3 per 100 person-years; AIDS rates were 50.5, 32.9, 11.5, 4.8, 2.8, 2.2, and 2.2 per 100 person-years; and loss-to-follow-up rates were 4.9, 6.1, 3.5, 3.1, 2.9, 1.7, and 1.2 per 100 person-years, respectively. Mortality and morbidity were higher during the first year after ART initiation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In these resource-limited settings, death and AIDS rates remained substantial after ART initiation, even in individuals with high CD4 cell counts. Ensuring earlier ART initiation and optimizing case finding and treatment for AIDS-defining diseases should be seen as priorities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gabillard</LastName><ForeName>Delphine</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>INSERM, U897, Université Bordeaux Segalen, Bordeaux, France. delphine.gabillard@isped.u-bordeaux2.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewden</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ndoye</LastName><ForeName>Ibra</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Moh</LastName><ForeName>Raoul</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Segeral</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Tonwe-Gold</LastName><ForeName>Besigin</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Etard</LastName><ForeName>Jean-François</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Pagnaroat</LastName><ForeName>Men</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Fournier-Nicolle</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Eholié</LastName><ForeName>Serge</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Konate</LastName><ForeName>Issouf</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Minga</LastName><ForeName>Albert</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mpoudi-Ngole</LastName><ForeName>Eitel</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Koulla-Shiro</LastName><ForeName>Sinata</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Zannou</LastName><ForeName>Djimon Marcel</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Anglaret</LastName><ForeName>Xavier</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Laurent</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><CollectiveName>ANRS 12222 Morbidity Mortality Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI058736</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Acquir Immune Defic Syndr</MedlineTA><NlmUniqueID>100892005</NlmUniqueID><ISSNLinking>1525-4135</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2012 Mar 1;54(5):714-23</RefSource><PMID Version="1">22173233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2010 Jul 21;304(3):321-33</RefSource><PMID Version="1">20639566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2012 May 1;60(1):91-8</RefSource><PMID Version="1">22293548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2012 Jul 17;26(11):1393-8</RefSource><PMID Version="1">22441247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Aug 7;376(9739):449-57</RefSource><PMID Version="1">20638120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2003 Jul 5;362(9377):22-9</RefSource><PMID Version="1">12853195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>HIV Med. 2005 May;6(3):216-23</RefSource><PMID Version="1">15876289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2005 Dec 2;19(18):2141-8</RefSource><PMID Version="1">16284464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 Mar 11;367(9513):817-24</RefSource><PMID Version="1">16530575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Public Health Policy. 2010 Dec;31(4):401-6</RefSource><PMID Version="1">21119647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2011 Mar 27;25(6):851-5</RefSource><PMID Version="1">21330903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 Aug 11;365(6):493-505</RefSource><PMID Version="1">21767103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2011 Sep 26;171(17):1560-9</RefSource><PMID Version="1">21949165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2011 Nov;11(11):825-33</RefSource><PMID Version="1">21831714</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2011;343:d6792</RefSource><PMID Version="1">22074711</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):213-9</RefSource><PMID Version="1">22027874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2006 May 12;20(8):1181-9</RefSource><PMID Version="1">16691070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2007 Nov 30;21(18):2483-91</RefSource><PMID Version="1">18025885</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2007 Nov;23(11):1338-47</RefSource><PMID Version="1">18184075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2008 Mar 1;371(9614):752-9</RefSource><PMID Version="1">18313504</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2008 Apr 23;22(7):873-82</RefSource><PMID Version="1">18427206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2008 May 10;371(9624):1603-11</RefSource><PMID Version="1">18468544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2008 Jul 8;5(7):e148</RefSource><PMID Version="1">18613745</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2009 Jan 28;23(3):335-42</RefSource><PMID Version="1">19114870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2009 Apr 18;373(9672):1352-63</RefSource><PMID Version="1">19361855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2009 Apr 28;6(4):e1000066</RefSource><PMID Version="1">19399157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Apr 30;360(18):1815-26</RefSource><PMID Version="1">19339714</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009;4(6):e5790</RefSource><PMID Version="1">19495419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2009 Aug 4;151(3):157-66</RefSource><PMID Version="1">19620143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Jan 9;375(9709):123-31</RefSource><PMID Version="1">20004464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2010;10:179</RefSource><PMID Version="1">20565900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2012 Apr;41(2):433-45</RefSource><PMID Version="1">22493325</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017954" MajorTopicYN="N" Type="Geographic">Africa South of the Sahara</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">NIHMS517956</OtherID><OtherID Source="NLM">PMC3921662</OtherID><InvestigatorList><Investigator ValidYN="Y"><LastName>Anglaret</LastName><ForeName>Xavier</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colebunders</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dabis</LastName><ForeName>François</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drabo</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eholié</LastName><ForeName>Serge</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabillard</LastName><ForeName>Delphine</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Girard</LastName><ForeName>Pierre-Marie</ForeName><Initials>PM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lacombe</LastName><ForeName>Karine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laurent</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Le Moing</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewden</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allou</LastName><ForeName>Gérard</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amani-Bossé</LastName><ForeName>Clarisse</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avit</LastName><ForeName>Divine</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benalycherif</LastName><ForeName>Aida</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Beaudrap</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boullé</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coffie</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coulibaly</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delaportee</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Denoeud</LastName><ForeName>Lise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diagbouga</LastName><ForeName>Serge</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koumavi Ekouevi</LastName><ForeName>Didier</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Etard</LastName><ForeName>Jean-François</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eymard-Duvernay</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fassinou</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fournier-Nicolle</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hien</LastName><ForeName>Hervé</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huet</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Konate</LastName><ForeName>Issouf</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koulla-Shiro</LastName><ForeName>Sinata</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leroy</LastName><ForeName>Valériane</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcy</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Régis Martin</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meda</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Messou</LastName><ForeName>Eugène</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minga</LastName><ForeName>Albert</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mpoudi-Ngolé</LastName><ForeName>Eitel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Msellati</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nacro</LastName><ForeName>Boubacar</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagot</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ndoye</LastName><ForeName>Ibra</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>N'Dri-Yoman</LastName><ForeName>Thérèse</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ouédraogo</LastName><ForeName>Abdoulaye</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ouk</LastName><ForeName>Vara</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pagnaroat</LastName><ForeName>Men</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salamon</LastName><ForeName>Roger</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saphonn</LastName><ForeName>Vonthanak</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Segeral</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seyler</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tonwe-Gold</LastName><ForeName>Besigin</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Traore</LastName><ForeName>Moussa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van de Perre</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Viho</LastName><ForeName>Ida</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zannou</LastName><ForeName>Marcel</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23274931</ArticleId><ArticleId IdType="doi">10.1097/QAI.0b013e3182821821</ArticleId><ArticleId IdType="pmc">PMC3921662</ArticleId><ArticleId IdType="mid">NIHMS517956</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001008 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001008 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23274931
|texte= Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23274931" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |